203 related articles for article (PubMed ID: 15216472)
1. Immunization with the truncated adhesin moraxella catarrhalis immunoglobulin D-binding protein (MID764-913) is protective against M. catarrhalis in a mouse model of pulmonary clearance.
Forsgren A; Brant M; Riesbeck K
J Infect Dis; 2004 Jul; 190(2):352-5. PubMed ID: 15216472
[TBL] [Abstract][Full Text] [Related]
2. Intranasal vaccination with recombinant outer membrane protein CD and adamantylamide dipeptide as the mucosal adjuvant enhances pulmonary clearance of Moraxella catarrhalis in an experimental murine model.
Becker PD; Bertot GM; Souss D; Ebensen T; Guzmán CA; Grinstein S
Infect Immun; 2007 Apr; 75(4):1778-84. PubMed ID: 17101651
[TBL] [Abstract][Full Text] [Related]
3. Exploration of Moraxella catarrhalis outer membrane proteins, CD and UspA, as new carriers for lipooligosaccharide-based conjugates.
Hu WG; Berry J; Chen J; Gu XX
FEMS Immunol Med Microbiol; 2004 Jun; 41(2):109-15. PubMed ID: 15145454
[TBL] [Abstract][Full Text] [Related]
4. MID and UspA1/A2 of the human respiratory pathogen Moraxella catarrhalis, and interactions with the human host as basis for vaccine development.
Riesbeck K; Tan TT; Forsgren A
Acta Biochim Pol; 2006; 53(3):445-56. PubMed ID: 16964325
[TBL] [Abstract][Full Text] [Related]
5. Current progress of adhesins as vaccine candidates for Moraxella catarrhalis.
Tan TT; Riesbeck K
Expert Rev Vaccines; 2007 Dec; 6(6):949-56. PubMed ID: 18377357
[TBL] [Abstract][Full Text] [Related]
6. Moraxella catarrhalis outer membrane protein CD elicits antibodies that inhibit CD binding to human mucin and enhance pulmonary clearance of M. catarrhalis in a mouse model.
Liu DF; McMichael JC; Baker SM
Infect Immun; 2007 Jun; 75(6):2818-25. PubMed ID: 17403868
[TBL] [Abstract][Full Text] [Related]
7. Immunoinformatics Identifies a Lactoferrin Binding Protein A Peptide as a Promising Vaccine With a Global Protective Prospective Against Moraxella catarrhalis.
Yassin GM; Amin MA; Attia AS
J Infect Dis; 2016 Jun; 213(12):1938-45. PubMed ID: 26908723
[TBL] [Abstract][Full Text] [Related]
8. Human serum and mucosal antibody responses to outer membrane protein G1b of Moraxella catarrhalis in chronic obstructive pulmonary disease.
Adlowitz DG; Kirkham C; Sethi S; Murphy TF
FEMS Immunol Med Microbiol; 2006 Feb; 46(1):139-46. PubMed ID: 16420607
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the serological responses to Moraxella catarrhalis immunoglobulin D-binding outer membrane protein and the ubiquitous surface proteins A1 and A2.
Tan TT; Christensen JJ; Dziegiel MH; Forsgren A; Riesbeck K
Infect Immun; 2006 Nov; 74(11):6377-86. PubMed ID: 16966403
[TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of a novel outer membrane protein (OMP J) of Moraxella catarrhalis that exists in two major forms.
Hays JP; van Selm S; Hoogenboezem T; Estevão S; Eadie K; van Veelen P; Tommassen J; van Belkum A; Hermans PW
J Bacteriol; 2005 Dec; 187(23):7977-84. PubMed ID: 16291671
[TBL] [Abstract][Full Text] [Related]
11. The IgD-binding domain of the Moraxella IgD-binding protein MID (MID962-1200) activates human B cells in the presence of T cell cytokines.
Nordström T; Jendholm J; Samuelsson M; Forsgren A; Riesbeck K
J Leukoc Biol; 2006 Feb; 79(2):319-29. PubMed ID: 16301327
[TBL] [Abstract][Full Text] [Related]
12. Current progress with Moraxella catarrhalis antigens as vaccine candidates.
Mawas F; Ho MM; Corbel MJ
Expert Rev Vaccines; 2009 Jan; 8(1):77-90. PubMed ID: 19093775
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of pulmonary clearance of Moraxella (Branhamella) catarrhalis following immunization with outer membrane protein CD in a mouse model.
Murphy TF; Kyd JM; John A; Kirkham C; Cripps AW
J Infect Dis; 1998 Dec; 178(6):1667-75. PubMed ID: 9815219
[TBL] [Abstract][Full Text] [Related]
14. Reduction of nasal colonization of nontypeable Haemophilus influenzae following intranasal immunization with rLP4/rLP6/UspA2 proteins combined with aqueous formulation of RC529.
Mason KW; Zhu D; Scheuer CA; McMichael JC; Zlotnick GW; Green BA
Vaccine; 2004 Sep; 22(25-26):3449-56. PubMed ID: 15308371
[TBL] [Abstract][Full Text] [Related]
15. Mucosal immune response to specific outer membrane proteins of Moraxella catarrhalis in young children.
Meier PS; Freiburghaus S; Martin A; Heiniger N; Troller R; Aebi C
Pediatr Infect Dis J; 2003 Mar; 22(3):256-62. PubMed ID: 12634588
[TBL] [Abstract][Full Text] [Related]
16. Immune evasion of Moraxella catarrhalis involves ubiquitous surface protein A-dependent C3d binding.
Hallström T; Nordström T; Tan TT; Manolov T; Lambris JD; Isenman DE; Zipfel PF; Blom AM; Riesbeck K
J Immunol; 2011 Mar; 186(5):3120-9. PubMed ID: 21270401
[TBL] [Abstract][Full Text] [Related]
17. Effect of immunization of pulmonary clearance of Moraxella catarrhalis in an animal model.
Maciver I; Unhanand M; McCracken GH; Hansen EJ
J Infect Dis; 1993 Aug; 168(2):469-72. PubMed ID: 8335988
[TBL] [Abstract][Full Text] [Related]
18. Substrate binding protein SBP2 of a putative ABC transporter as a novel vaccine antigen of Moraxella catarrhalis.
Otsuka T; Kirkham C; Johnson A; Jones MM; Murphy TF
Infect Immun; 2014 Aug; 82(8):3503-12. PubMed ID: 24914218
[TBL] [Abstract][Full Text] [Related]
19. Immunological characterisation of truncated lipooligosaccharide-outer membrane protein based conjugate vaccine against Moraxella catarrhalis and nontypeable Haemophilus influenzae.
Singh S; Wilson JC; Cripps AW; Massa H; Ozberk V; Grice ID; Peak IR
Vaccine; 2020 Jan; 38(2):309-317. PubMed ID: 31668366
[TBL] [Abstract][Full Text] [Related]
20. Multicomponent Moraxella catarrhalis outer membrane vesicles induce an inflammatory response and are internalized by human epithelial cells.
Schaar V; de Vries SP; Perez Vidakovics ML; Bootsma HJ; Larsson L; Hermans PW; Bjartell A; Mörgelin M; Riesbeck K
Cell Microbiol; 2011 Mar; 13(3):432-49. PubMed ID: 21044239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
